Raymond James & Associates’s Vaxcyte PCVX Stock Holding History

Raymond James & Associates’s Portfolio PCVX Stock Details PCVX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$9.28M	Buy
2024 Q2	$5.24M	Buy
2024 Q1	$4.53M	Buy
2023 Q4	$3.24M	Sell
2023 Q3	$2.75M	Sell
2023 Q2	$2.73M	Buy
2023 Q1	$285K	Buy